---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-060416"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2022-05-13T23:59:59+00:00"
generated_at: "2026-06-25T16:48:24.351333+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics appoints David Jin as Interim Principal Financial Officer

## Summary
- David Jin, 32, appointed Interim Principal Financial Officer effective May 11, 2022.
- Jin also serves as Interim Principal Executive Officer and Chief Operating Officer.
- Jin is VP of Corporate Development at Fortress Biotech; prior roles include Barings, Sorrento Therapeutics, FBR & Co, IMS Health.
- No family relationships with directors or executive officers; no reportable transactions.

## SEC filing metadata
- accession: 0001104659-22-060416
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2022-05-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465922060416/0001104659-22-060416-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465922060416/tm2215290d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-060416
- JSON: https://secwatch.observer/filing/0001104659-22-060416.json
- Plain text: https://secwatch.observer/filing/0001104659-22-060416.txt

## Key facts
- Executive change
  David Jin was appointed as Interim Principal Financial Officer at AVENUE THERAPEUTICS, INC..
  - Action: appointed
  - Role: Interim Principal Financial Officer
  source text: On May 11, 2022, Avenue Therapeutics, Inc. (the “Company”) appointed David Jin as the Company’s Interim Principal Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465922060416/0001104659-22-060416-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.